newsfilter
← Latest News
Business Wire·

Spruce Biosciences Announces Data Presentations at the 22nd Annual WORLDSymposium™

Spruce Biosciences, Inc. (NASDAQ:SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced